Hypoxia activates the human placental vascular endothelial growth factor system in vitro and in vivo: Up-regulation of vascular endothelial growth factor in clinically relevant hypoxic ischemia in birth asphyxia

American Journal of Obstetrics and Gynecology

Volumn 188, Issue 2, 2003, Pages 517-523

  Trollmann, Regina ^a   Amann, K ^a   Schoof, E ^a   Beinder, E ^a   Wenzel, D ^a   Rascher, W ^a   Dotsch J ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Birth asphyxia; Hypoxia; Placenta; Preeclampsia; Vascular endothelial growth factor

Indexed keywords

BETA ACTIN; MESSENGER RNA; VASCULOTROPIN;

ARTICLE; BRAIN HYPOXIA; BRAIN ISCHEMIA; CHORIOCARCINOMA; HUMAN; HUMAN CELL; IMMUNOHISTOLOGY; PERINATAL ASPHYXIA; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

EID: 0037327710     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2003.138     Document Type: Article

References (27)

1. Semenza GL. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 2000;88:1474-80.
2. Kingdom J, Huppertz B, Seaward G, Kaufmann P. Development of the placental villous tree and its consequences for fetal growth. Eur J Obstet Gynecol 2000;92:35-43.
3. Cheung CY. Vascular endothelial cell growth factor: possible role in fetal development and placental function. J Soc Gynecol Invest 1997;4:169-77.
4. Keyt BA, Nguyen HV, Berleau LT, Duarte CM, Park J, Chen H, et al. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors: generation of receptor-selective VEGF variants by site-directed mutagenesis. J Biol Chem 1996;271:5638-46.
5. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH. Different signal transduction properties of KDR and flt-1, two receptors for vascular endothelial growth factor. J Biol Chem 1994;269:26988-95.
6. Cooper JC, Sharkey AM, McLaren J, Charnock-Jones DS, Smith SK. Localization of vascular endothelial growth factor and its receptor, flt, in human placenta and decidua by immunhistochemistry. J Reprod Fertil 1995;105:205-13.
7. Clark DE, Smith SK, Licence D, Evans AL, Charnock-Jones DS. Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation. J Endocrinol 1998;159:459-67.
8. Helske S, Vuorela P, Carpen O, Hornig C, Weich H, Halmesmäki E. Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies. Mol Hum Reprod 2001;7:205-10.
9. Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR, Torry DS. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblasts. Placenta 1997;18:657-65.
10. Breier G. Angiogenesis in embryonic development. Placenta 2000;21 (Suppl):511-5.
11. Gille H, Kowalski J, Bing L, LeCouter J, Moffat B, Zioncheck TF, et al. Analysis of biological effects and signaling properties of flt-1 (VEGFR-1) and KDR (VEGFR-2). J Biol Chem 2001;276:3220-2.
12. Jin KL, Mao XO, Greenberg DA. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci U S A 2000;97:10242-7.
13. Taylor CM, Stevens H, Nathony FW, Wheeler T. Influence of hypoxia on vascular endothelial growth factor and chorionic gonadotrophin production in the trophoblast-derived cell lines: JEG, Jar and BeWo. Placenta 1997;18:451-8.
14. Ahmed A, Dunk C, Ahmad S, Khaliq A. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen: a review. Placenta 2000;21:S16-S24.
15. Khaliq A, Dunk C, Jiang J, Shams M, Li XF, Acevedo C, et al. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for placental hypoxia in intrauterine growth restriction. Lab Invest 1999;79:151-70.
16. Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress: a clinical and encephalographic study. Arch Neurol 1976;33:696-705.
17. Davey DA, MacGillivray I. The classification of hypertensive disorders in pregnancy. In: Sharp F, Symonds EM, editors. Hypertension in pregnancy. New York: Perinatology Press; 1987. p. 401-15.
18. Dötsch J, Nuesken KD, Knerr I, Kirschbaum M, Repp R, Rascher W. Leptin and neuropeptide Y gene expression in human placenta: ontogeny and evidence for similarities to hypothalamic regulation. J Clin Endocrinol Metab 1999;84:2765-8.
19. Charnock-Jones DS, Sharkey AM, Boocock CA, Ahmed A, Plevin R, Ferrara N, et al. Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells. Biol Reprod 1994;51:524-30.
20. Brogi E, Schatteman G, Wu T, Kim EA, Varticovski L, Keyt B, et al. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest 1996;97:469-76.
21. Tuder RM, Flook BE, Voelkel NF. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia: modulation of gene expression by nitric oxide. J Clin Invest 1995;95:1798-807.
22. Warren RS, Yuan H, Matli MR, Gillett NA, Ferrara N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 1995;95:1789-97.
23. Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V, et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway: requirement for Flk-1/KDR activation. J Biol Chem 1998;273:30336-43.
24. Waltenberger J, Mayr U, Pentz S, Hombac̀h V. Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. Circulation 1996;94:1647-54.
25. Simmons LA, Hennessy A, Gillin AG, Jeremy RW. Uteroplacental blood flow and placental vascular endothelial growth factor in normotensive and pre-eclamptic pregnancy. Br J Obstet Gynaecol 2000;107:678-85.
26. He Y, Smith SK, Day KA, Clark DE, Licence DR, Charnock-Jones DS. Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (flt-1) pre-mRNA is important for the regulation of VEGF activity. Mol Endocrinol 1999;13:537-45.
27. Shen BQ, Lee DY, Gerber HP, Keyt BA, Ferrara N, Zioncheck TF. Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro. J Biol Chem 1998;273:29979-85.